Daxor Corporation to Exhibit at the MedAxiom Cardiovascular Transforum Conference Spring’23 to Advance Awareness and Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100®)
17 avr. 2023 08h00 HE
|
Daxor Corporation
Expert Users to Present “Blood Volume Analysis – Breaking the Heart Failure Cycle” Oak Ridge, TN, April 17, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...
Daxor Corporation to Exhibit at the 43rd International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
13 avr. 2023 08h00 HE
|
Daxor Corporation
Company to Showcase Three New Research Studies Utilizing Blood Volume Analysis Oak Ridge, TN, April 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
New Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients
23 mars 2023 08h30 HE
|
Daxor Corporation
Commonly Used Pressure Measure for Volume Assessment Discordant with Direct Measurement by BVA Oak Ridge, TN, March 23, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in...
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
23 mars 2023 08h00 HE
|
Daxor Corporation
BVA Feasibly Guides Fluid Management with Greater Accuracy than Traditional MeansResearchers Conclude that a Larger Powered RCT is Warranted Oak Ridge, TN, March 23, 2023 (GLOBE NEWSWIRE) -- Daxor...
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
03 mars 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, March 03, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to...
Daxor Corporation Reports a 37% Increase in NAV to $6.75 Per Share for the Year Ended December 31, 2022
02 mars 2023 07h00 HE
|
Daxor Corporation
Conference Call to be held today at 9:00 AM EST Oak Ridge, TN, March 02, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, filed...
Daxor Corporation to Report Fiscal Year 2022 Financial Results on Wednesday, March 1, 2023 and Provide Corporate Update
01 mars 2023 08h00 HE
|
Daxor Corporation
Conference Call to be held at 9 AM EST March 2, 2023 Oak Ridge, TN, March 01, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology,...
Daxor Corporation Appoints Linda Cooper, Vice President Project Management
17 févr. 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Linda Cooper as Vice...
Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member
19 janv. 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces joining the Heart Failure Society of...
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
13 janv. 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be presenting at the Society for...